I think this is essentially unprecedented and I doubt any pharmacies would be allowed to stock it let alone dispense it without calling the FDA/manufacturer directly and getting case by case approval to apply it under clinical supervision. The approval does clear the bureaucratic hurdles to transporting across state lines and getting it into the hands of a doctor quickly in the emergency event that smallpox returns.
Edit: Their Phase 3 trial [1] appears to be the equivalent to a regular Phase 1 trial where the dosage of the drug is increased under clinical supervision until side effects become intolerable for 50% of the patients to find a safe maximum dose. This means that they tested safety in vivo on humans already and instead of showing efficacy (whether it actually does what it is supposed to do vs a placebo) on humans, they were allowed to do it with animals. They used 449 18 to 80 year old patients which is quite a bit more than usual for a safety phase so they can be reasonably certain it won't make the situation worse in the event of smallpox.
They do get paid and there really is no ethical alternative. By definition, zero drugs would have a "plausible health benefit" at this stage because you're trying to figure the negative effects and a maximum safe dose without having confounding effects from the disease you are trying to treat.